Rituximab failed to improve survival after stem cell transplant for DLBCL

Gisselbrecht C. J Clin Oncol. 2012;doi:10.1200/JCO.2012.41.9416.
Source: HemOncToday.com - Category: Cancer & Oncology Source Type: news